Asenapine versus olanzapine in the treatment of impulsivity, aggression, and self injuries in patients with borderline personality disorder.
Phase of Trial: Phase IV
Latest Information Update: 16 Jul 2019
Price : $35 *
At a glance
- Drugs Asenapine (Primary) ; Olanzapine
- Indications Borderline personality disorders
- Focus Therapeutic Use
- 24 Jul 2017 Primary endpoint (Global symptoms assessed with the Clinical Global Impression Scale (CGI-S)) has not been met, according to results published in the CNS Drugs Journal.
- 24 Jul 2017 Status changed from recruiting to completed, according to results published in the CNS Drugs Journal.
- 24 Jul 2017 Results published in the CNS Drugs Journal.